697
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Conventional- versus high-dose vancomycin regimen in patients with acute bacterial meningitis: a randomized clinical trial

, , PharmD PhD (Professor) , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mersedeh Shayan & Sepideh Elyasi. (2020) Cilastatin as a protective agent against drug-induced nephrotoxicity: a literature review. Expert Opinion on Drug Safety 19:8, pages 999-1010.
Read now

Articles from other publishers (4)

Shu-Ping Liu, Jing Xiao, Ya-Li Liu, Yue-E Wu, Hui Qi, Zhuang-Zhuang Wang, A-Dong Shen, Gang Liu & Wei Zhao. (2022) Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections. Frontiers in Pharmacology 13.
Crossref
Go Okamoto, Emari Furuya, Daisuke Ito, Miki Sawai, Kanae Terada & Emiko Kobayashi. (2022) Pharmacokinetic variability of vancomycin in patients with nosocomial meningitis. Journal of Clinical Pharmacy and Therapeutics 47:11, pages 1752-1758.
Crossref
Ajaree Rayanakorn, Hooi-Leng Ser, Priyia Pusparajah, Kok-Gan Chan, Bey Hing Goh, Tahir Mehmood Khan, Surasak Saokaew, Shaun Wen Huey Lee & Learn-Han Lee. (2020) Comparative efficacy of antibiotic(s) alone or in combination of corticosteroids in adults with acute bacterial meningitis: A systematic review and network meta-analysis. PLOS ONE 15:5, pages e0232947.
Crossref
Iman Karimzadeh, Ghazaleh Haghighati, Mani Ramzi, Mohammad Mahdi Sagheb & Kamiar Zomorodian. (2016) Assessing the Epidemiology of Nephrotoxicity and the Role of Urinary Kidney Injury Molecule 1 as a Biomarker of Renal Function in Hematologic-Oncologic Patients Under Vancomycin Treatment in Shiraz, Iran. Iranian Red Crescent Medical Journal 19:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.